Deciphera Pharmaceuticals Inc
Price
$25.61
Today
+0.0%
YTD
+0.2%
Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on developing drugs targeted at treating serious and rare forms of cancer. Its solutions serve medical communities across the world. It operates in the biotechnology industry, providing treatments that directly inhibit tumour kinases, a type of enzyme cancer cells need for survival. The company uses its switch-control kinase inhibitor platform to develop a portfolio of medicines, including two clinical-stage drug candidates and its approved drug, QINLOCK. Monitor the DCPH share price by adding it to your eToro watchlist.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Valuation
Profitability
Earnings & Revenue
Dividends & Risk
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.